0001209191-22-046225.txt : 20220817
0001209191-22-046225.hdr.sgml : 20220817
20220817160542
ACCESSION NUMBER: 0001209191-22-046225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silver Ronald
CENTRAL INDEX KEY: 0001873731
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 221174019
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET
STREET 2: SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-15
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001873731
Silver Ronald
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET SUITE 2300
BOSTON
MA
02110
0
1
0
0
Principal Accounting Officer
Class A Common Stock
2022-08-15
4
S
0
2014
11.77
D
105151
D
The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022.
/s/ Ronald Silver, Attorney-in-Fact
2022-08-17